SKYSTAR BIO-PHARMACEUTICAL CO: 10-Q/A filed 2011-09-21
What SKYSTAR BIO-PHARMACEUTICAL CO reported in its quarterly report amendment filed 2011-09-21 (fiscal Q2 2011): 34 published measures, 98 facts as tagged in accession 0001144204-11-054104.
This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.
This filing
- Form
- 10-Q/A (quarterly report amendment)
- Filed
- 2011-09-21
- Fiscal period
- fiscal Q2 2011
- Accession
- 0001144204-11-054104 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SKYSTAR BIO-PHARMACEUTICAL CO filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 86,420,701 | USD | |
| At 2010-12-31 | 81,249,131 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 9,895,478 | USD | |
| At 2010-12-31 | 9,759,302 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 76,525,223 | USD | |
| At 2010-12-31 | 71,489,829 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 5,046,502 | USD | |
| At 2010-12-31 | 5,887,831 | USD | |
| At 2010-06-30 | 3,482,558 | USD | |
| At 2009-12-31 | 11,699,398 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 1,507,390 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 3,439,222 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 2,378,395 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 3,474,642 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -3,922,845 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 553,227 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 1,302,209 | USD | 181 |
| 2010-01-01 to 2010-06-30 | -377,927 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 1,604,317 | USD | 181 |
| 2010-01-01 to 2010-06-30 | -8,403,458 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 28,286,512 | USD | |
| At 2010-12-31 | 24,847,290 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 7,169,419 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 7,168,176 | shares | 181 |
| 2010-04-01 to 2010-06-30 | 7,104,606 | shares | 91 |
| 2010-01-01 to 2010-06-30 | 7,083,149 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 7,169,419 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 7,174,888 | shares | 181 |
| 2010-04-01 to 2010-06-30 | 7,140,518 | shares | 91 |
| 2010-01-01 to 2010-06-30 | 7,119,846 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 0.21 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | 0.48 | USD/shares | 181 |
| 2010-04-01 to 2010-06-30 | 0.33 | USD/shares | 91 |
| 2010-01-01 to 2010-06-30 | 0.49 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 0.21 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | 0.48 | USD/shares | 181 |
| 2010-04-01 to 2010-06-30 | 0.33 | USD/shares | 91 |
| 2010-01-01 to 2010-06-30 | 0.49 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 281,705 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 759,155 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 540,486 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 865,805 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 1,532,464 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 3,176,398 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 2,737,546 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 4,480,891 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 45,619,110 | USD | |
| At 2010-12-31 | 44,740,779 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 8,565,936 | USD | |
| At 2010-12-31 | 7,353,613 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 789,758 | USD | |
| At 2010-12-31 | 201,850 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 3,979,063 | USD | |
| At 2010-12-31 | 4,977,850 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 2,926,670 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 4,878,344 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 1,621,932 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 2,456,611 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 16,146,631 | USD | |
| At 2010-12-31 | 7,202,223 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 4,459,134 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 8,054,742 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 4,359,478 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 6,937,502 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 1,801,551 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 2,089,023 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 192,088 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 236,083 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 7,161,919 | shares | |
| At 2010-12-31 | 7,161,919 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 6,751,935 | USD | |
| At 2010-12-31 | 5,155,763 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 5,820,403 | USD | |
| At 2010-12-31 | 6,043,941 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 2,637,969 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 5,035,394 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 2,659,393 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 3,714,824 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 515,293 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,810,091 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 998,034 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 1,617,584 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 498,760 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 299,848 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -4,549 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -4,367 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 36,257 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 36,674 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 256,631 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,021,979 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 181,335 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -140,444 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -1,085,951 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 3,584,456 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 8,711,510 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 9,252,221 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 577,915 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 253,565 | USD | 181 |
Inspect the source
- Entity
- SKYSTAR BIO-PHARMACEUTICAL CO / CIK 0001076939
- Captured
- SEC response SHA-256
d8a65cf54c4bf27fa61797f1bd20f2af91d87c7c6e9bd44fc78d05c68ff517d1
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001076939.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))